TopNews + Font Resize -

MMRCDA demands vigilance inquiry against FDA official for misguiding senior officials
Ramesh Shankar, Mumbai | Thursday, March 24, 2011, 08:00 Hrs  [IST]

The Maha-Mumbai Retail Chemists and Distributors Association (MMRCDA) has demanded a vigilance inquiry against Dr S R Sharma, joint commissioner, FDA, Thane for favouring pharma major Sun Pharmaceuticals' C&F agents Aditya Medisales, against whom the MMRCDA had some time back complained to the FDA for refusing to sell some of the life-saving drugs to some drug dealers in violation of DPCO norms.

In a memorandum to the Joint Commissioner (Vigilance), FDA, Maharashtra, the MMRCDA has alleged that Dr Sharma has narrated, in his written submission to joint commissioner, HQ vide reference no: 868/2010/8 dated 14-12-2010, that the life saving drugs not dispatched were belonging to INCA Division of Sun Pharmaceuticals Limited. He also explained the complainant status as ‘Hospital supplier’ causing it a reason for not having supplied as per requisites.

“We beg to state that in the Drugs Act or Supplementary Acts, no separate provisions or limitations are there for hospital or trade suppliers. Further it is the internal business interest and advantage of the Sun Pharmaceuticals to float wings or divisions, though they are operating products under one single license, which you must note down”, the letter said.

Making allegations that Aditya Medisales has misled the FDA authorities by giving false reasons or the joint commissioner of Thane Dr S R Sharma  has misguided the joint commissioner of HQ, Maharashtra, the MMRCDA said that on page two of Dr Sharma's letter to  joint commissioner of HQ, Maharashtra, there is a chart which shows the reasons given by Aditya Medisales for non supply of drugs. In view of this, there are many products which are omitted and only few products are shown.

In the above mentioned chart there are products where M/s Aditya Medisales has given reasons that he has not received the order. For example, ovurelix inj order dt 13.4.2010 the reason given is order not received, but the actual fact is M/s Aditya Medisales has supplied other product included in the same order copy of ovurelix inj.

The order dt 13.4.2010 of M/s Hemraj Mulji to Aditya Medisales consisted of 4 products, whereas Adiya Medisales has supplied only one product vide their inv no 000041b01448 dt 21.4.2010 and whereas in the above chart only 2 products were shown and one was omitted. Secondly in the chart as mentioned above Adiya Medisales has given reason that he has not received the order at the same time he has supplied one product of the same order copy.

“We are enclosing all details and request you to please investigate the issue seriously in the department”, the letter said.

The MMRCDA has also submitted a memorandum to state minister Sandesh alias Bunty Patil in this regard.

Comments

FELIX FERNANDES Mar 26, 2011 9:35 PM
COULD YOU PLEASE PROVIDE SOME MORE DETAILS ABOUT THE ALLEGATIONS FOR PUBLICATION IN THE TIMES OF INDIA. SOFT COPY OR THE DOCUMENTS AND THE LETTER WILL SUFFICE. ALSO SEND IMPORTANT TEL/CELL NOS FOR CROSS EXAMINATION.

FROM:

FELIX FERNANDES REPORTER TIMES OF INDIA[ NAVI MUMBAI AND THAN
MANGAL CHOLERA Mar 24, 2011 9:26 AM
DEPARTMENTAL ENQ SHOULD BE FOLLOWED TO FIND TRUTH BEHIND SUCH FAVORISM WHICH CREATE SHORTAGES / NON AVAILABLITIES OF MEDICINES OR DEPRIVING DISTRIBUTORS FROM SUPPLY AGAINST THERE ORDERS.

Post Your Comment

 

Enquiry Form